Product image of Norditropin Flexpro (Somatropin) supplied by GNH India

Norditropin Flexpro

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin FlexPro, is a growth hormone presented as a 5 mg per pen (3.33 mg/mL) injectable solution for subcutaneous use. It treats growth hormone deficiency and related growth disorders in children and adults, and is indicated for several endocrine conditions that affect linear growth.

GNH India supplies Norditropin FlexPro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable cold‑chain logistics and regulatory support with a focus on quality assurance and timely delivery to meet clinical demand.

Manufacturer / TM Owner

Novo Nordisk Pharma

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin FlexPro (somatropin) is used in endocrine therapy to address growth hormone deficiency and related conditions.

  • Growth hormone deficiency in children: promotes linear growth and improves height velocity.
  • Turner syndrome: supports growth and development during puberty.
  • Prader‑Willi syndrome: enhances growth and body composition.
  • Chronic renal insufficiency associated growth failure: aids in achieving normal growth patterns.
  • Short stature due to idiopathic causes: stimulates growth in otherwise healthy children.
  • Adult growth hormone deficiency: improves body composition, bone density and quality of life.

How It Works

  • Somatropin binds to growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling cascade. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1) and other downstream mediators, leading to increased protein synthesis, cell proliferation, and linear growth in bone and cartilage.

Side Effects

Somatropin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Injection site reactions: redness, swelling, or pain at the injection site.
  • Headache: mild to moderate intensity.
  • Joint stiffness: transient discomfort in joints.
  • Edema: mild fluid retention, especially in extremities.
  • Hyperglycemia: elevated blood glucose levels, often mild.

Serious or Rare Side Effects

  • Intracranial hypertension: signs include severe headache, visual changes, nausea.
  • Slipped capital femoral epiphysis: hip pain and limited motion.
  • Acute pancreatitis: abdominal pain, nausea, elevated enzymes.
  • Allergic reactions: rash, urticaria, anaphylaxis.
  • Neoplasia progression: potential acceleration of existing tumors.

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety measures.

  • Screening: assess baseline IGF‑1 and glucose levels before initiating therapy.
  • Monitoring: regularly evaluate growth response, IGF‑1, and metabolic parameters.
  • Diabetes risk: monitor for hyperglycemia, especially in patients with pre‑existing diabetes.
  • Intracranial pressure: watch for persistent headaches, visual disturbances.
  • Cancer history: avoid or use with caution in patients with active malignancies.
  • Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin can interact with several medication classes, requiring careful management.

Major Interactions (Avoid)

  • Glucocorticoids: may antagonize growth‑promoting effects.
  • Antidiabetic agents: somatropin can reduce glycemic control, requiring dose adjustment.
  • Estrogen therapy: high doses may interfere with IGF‑1 response.

Moderate Interactions (Monitor Closely)

  • Thyroid hormone replacement: monitor thyroid function as GH can increase conversion.
  • Oral contraceptives: may alter IGF‑1 levels, requiring periodic assessment.
  • Insulin: may need dose titration due to altered glucose metabolism.

Frequently Asked Questions

Norditropin FlexPro contains somatropin, a recombinant human growth hormone indicated for treating growth hormone deficiency in children and adults, as well as specific conditions such as Turner syndrome, Prader‑Willi syndrome, chronic renal insufficiency‑related growth failure, idiopathic short stature, and adult growth hormone deficiency.

Somatropin binds to growth hormone receptors on target cells, triggering the JAK2‑STAT5 pathway. This leads to increased hepatic production of insulin‑like growth factor‑1 (IGF‑1) and other anabolic mediators, which together stimulate protein synthesis, cell proliferation, and linear bone growth.

The dose of Norditropin FlexPro is individualized by the prescribing clinician based on the patient’s age, weight, severity of growth hormone deficiency, and treatment goals. Dosage adjustments are made during follow‑up visits according to growth response and laboratory monitoring.

Somatropin is classified as Pregnancy Category B, indicating no proven risk in animal studies but limited human data. It is generally avoided during pregnancy unless the potential benefit outweighs the risk. Breastfeeding mothers should consult their physician, as the drug may be present in milk.

To order Norditropin FlexPro, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and necessary import documentation.

Norditropin FlexPro offers a pre‑filled pen device that simplifies subcutaneous administration compared with vial‑and‑syringe formats. Its recombinant somatropin molecule is bioequivalent to other approved growth hormones, providing similar efficacy and safety, while the pen may improve adherence and dosing accuracy.

Norditropin FlexPro must be stored refrigerated at 2‑8 °C. Keep the pen in its original carton, protect it from light, and avoid freezing or shaking. If a short period at room temperature is unavoidable, the product may remain stable for up to 24 hours, after which it should be returned to refrigeration.

The medication is delivered subcutaneously using the pre‑filled pen. The prescriber selects the appropriate dose, and the patient or caregiver injects into a clean area of the thigh, abdomen or upper arm, rotating sites with each injection to reduce local reactions.

Serious adverse events include intracranial hypertension (severe headache, visual changes), slipped capital femoral epiphysis (hip pain, limited motion), acute pancreatitis, severe hyperglycemia, allergic reactions such as anaphylaxis, and possible acceleration of pre‑existing malignancies.

Norditropin FlexPro is contraindicated in patients with known hypersensitivity to somatropin or any excipients, those with active malignancies, uncontrolled diabetes, or severe acute illness. Caution is also advised for patients with a history of intracranial hypertension or orthopedic disorders that could be worsened by rapid growth.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT